SAM #36C25727Q0065

VA North Texas market research for ALBAcyte blood bank reagents

VA North Texas is seeking vendor capabilities for recurring blood bank reagent needs supporting transfusion testing. - Government buyer: Department of Veterans Affairs, VA North Texas Health Care System (VANTHCS), Network Contracting Office 17; Transfusion Medicine Unit, Pathology and Laboratory Medicine Service, Dallas, Texas. - Products and estimated annual quantities: - ALBAcyte A1 Cells, part number Z401U — 52 - ALBAcyte A2 Cells, part number Z406U — 13 - ALBAcyte B Cells, part number Z411U — 52 - ALBAcyte IgG Sensitized Cells (weak), part number Z4411U-1 — 26 - ALBAcyte Antibody ID Panel (16-cell), part number Z473U — 7 - ALBAcyte C3 Coated Red Blood Cells, part number Z482U — 13 - OEM and vendors: ALBAcyte is the named product line; no manufacturer or supplying vendor is identified in the provided information. - Key requirements: Vendors must provide evidence of FDA approval, maintain a defined quality plan and adequate supply, and identify each reagent’s manufacturing location in their capability statement. Reagents are to be delivered when ordered in suitable shipping containers; shipping and freight are FOB destination unless otherwise communicated. - Opportunity status and term: This is a sources-sought market research notice, not a solicitation or commitment to award. The anticipated term is five years: one base year plus four option years, with estimated quantities stated annually.

Description

THIS IS A SOURCES SOUGHT NOTICE ONLY. This notice does NOT constitute a request for quote (RFQ), request for proposal (RFP), or invitation for bid (IFB). No solicitation is currently available. This Sources Sought is issued solely for information and planning purposes to conduct market research and determine the availability and capability of qualified sources prior to determining the appropriate acquisition strategy.

I. General Information

• Agency/Office: Department of Veterans Affairs (VA), VA North Texas Health Care System (VANTHCS), 4500 S. Lancaster Rd. Dallas, TX. 75216
• Place of Performance: VA North Texas Health Care System, Pathology and Laboratory Medicine Service (P&LMS), Microbiology Laboratory, Dallas, Texas.
• Anticipated NAICS: 325413 In-Vitro Diagnostic Substance Manufacturing
• Anticipated PSC: 6550 In-Vitro Diagnostic Substances, Reagents, Test Kits and Sets.

The Government is seeking to identify responsible vendors capable of providing Blood Bank Reagents, used to perform patient manual blood typing and serum antibody detection and identification to be used in the Transfusion Medicine Unit, Pathology and Laboratory Medicine Services at VANTHCS. II. Description of Requirement Transfusion Medicine Unit, Pathology and Laboratory Medicine Services (P&LMS) at the VA North Texas Health Care System (VANTHCS), Dallas, TX is seeking blood reagents used to perform patient manual blood typing and serum antibody detection and identification testing used for cross matching blood for transfusions. The contemplated purchase includes, at a minimum: The Contractor shall provide reagent supplies as requested by VANTHCS staff to perform blood bank manual blood typing and serum antibody detection and identification testing used for cross matching blood for transfusions. Estimated Yearly Requirements: Item # Description/Part Number* Qty Unit 1 Z401U, ALBAcyte A1 Cells 52 EA 2 Z406U, ALBAcyte A2 Cells 13 EA 3 Z411U, ALBAcyte B Cells 52 EA 4 Z4411U-1, ALBAcyte IgG Sensitized Cells (weak) 26 EA 5 Z473U, ALBAcyte Antibody ID Panel (16-cell) 7 EA 6 Z482U, ALBAcyte C3 Coated Red Blood Cells 13 EA

 Period of Performance:

Base Year: 05/01/2027-04/30/2028 Option Year 1: 05/01/2028-04/30/2029 Option Year 2: 05/01/2029-04/30/2030 Option Year 3: 05/01/2030-04/30/2031 Option Year 4: 05/01/2031-04/30/2032

Location: The manual testing will be performed in Transfusion Medicine Unit, Pathology & Laboratory Medicine Service, VA North Texas Health Care System, 4500 S. Lancaster Rd., Dallas, TX 75216.

III. Performance requirements: Performance Requirements: The following are required: Packing and Delivery: All Shipping/Freight Charges will be FOB Destination unless noted otherwise by vendor and communicated to the contracting officer prior to award. The reagents shall be delivered at the time specified when the order is placed. The Contractor will furnish appropriate containers for shipment of the reagents.

Vendor must be approved by the FDA and shall provide documentation of approval.

Vendor must have a defined Quality plan, and Adequate supplies available.

IV. Submission Instructions Interested and capable vendors should submit an electronic capability statement and include the place of manufacture for all reagents listed in the sources sought via email in PDF or Word format by November 5, 2026, by 9:00 AM Central Standard Time.

• Teresa Arzola  
• Email: Teresa.arzola@va.gov  
• Subject line: Sources Sought Blood Bank Reagents VA North Texas HCS  

No telephone inquiries will be accepted. Responses received will be used solely for market research and planning purposes to assist the Government in determining an appropriate acquisition strategy (e.g., small business set aside or unrestricted). Submission of a capability statement is voluntary and shall not be construed as a commitment by the Government to issue a solicitation or award a contract, nor will the Government pay for information submitted in response to this Sources Sought. Additional Links:U.S Department of Veterans Affairs

View original listing